Literature DB >> 8448707

Tentative guidelines for using clinical and economic evaluations revisited.

A Laupacis1, D Feeny, A S Detsky, P X Tugwell.   

Abstract

Keywords:  Health Care and Public Health

Mesh：

Year:  1993        PMID： 8448707      PMCID： PMC1490721     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

Review 1.  Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.

Authors:  R J Labelle; J E Hurley
Journal:  J Health Econ       Date:  1992-10       Impact factor: 3.883

2.  The healthy-years equivalents: how to measure them using the standard gamble approach.

Authors:  A Mehrez; A Gafni
Journal:  Med Decis Making       Date:  1991 Apr-Jun       Impact factor: 2.583

3.  How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.

Authors:  A Laupacis; D Feeny; A S Detsky; P X Tugwell
Journal:  CMAJ       Date:  1992-02-15       Impact factor: 8.262

4.  Risk reduction from low osmolality contrast media. What do patients think it is worth?

Authors:  L J Appel; E P Steinberg; N R Powe; G F Anderson; S A Dwyer; R R Faden
Journal:  Med Care       Date:  1990-04       Impact factor: 2.983

5.  Methodology for measuring health-state preferences--II: Scaling methods.

Authors:  D G Froberg; R L Kane
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

Review 6.  A clinician's guide to cost-effectiveness analysis.

Authors:  A S Detsky; I G Naglie
Journal:  Ann Intern Med       Date:  1990-07-15       Impact factor: 25.391

Review 7.  Utility approach to measuring health-related quality of life.

Authors:  G W Torrance
Journal:  J Chronic Dis       Date:  1987

8.  A study to develop clinical decision rules for the use of radiography in acute ankle injuries.

Authors:  I G Stiell; G H Greenberg; R D McKnight; R C Nair; I McDowell; J R Worthington
Journal:  Ann Emerg Med       Date:  1992-04       Impact factor: 5.721

9.  What do patients value? Willingness to pay for ultrasound in normal pregnancy.

Authors:  D M Berwick; M C Weinstein
Journal:  Med Care       Date:  1985-07       Impact factor: 2.983

10.  A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer.

Authors:  D Feeny; W Furlong; R D Barr; G W Torrance; P Rosenbaum; S Weitzman
Journal:  J Clin Oncol       Date:  1992-06       Impact factor: 44.544
View more
  27 in total

1.  Costs in Perspective: Understanding Cost-Effectiveness Analysis.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?

Authors:  Bruce R Schackman; Heather Taffet Gold; Patricia W Stone; Peter J Neumann
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

3.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

Review 4.  Multi-attribute preference functions. Health Utilities Index.

Authors:  G W Torrance; W Furlong; D Feeny; M Boyle
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

5.  The emerging government requirement for economic evaluation of pharmaceuticals.

Authors:  M Drummond
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

6.  Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.

Authors:  J H E Yong; L Masucci; J S Hoch; R Sujic; D Beaton
Journal:  Osteoporos Int       Date:  2015-08-15       Impact factor: 4.507

Review 7.  Interpretation of cost-effectiveness analyses.

Authors:  D K Owens
Journal:  J Gen Intern Med       Date:  1998-10       Impact factor: 5.128

8.  Cost-effectiveness of a community-level HIV risk reduction intervention.

Authors:  S D Pinkerton; D R Holtgrave; W J DiFranceisco; L Y Stevenson; J A Kelly
Journal:  Am J Public Health       Date:  1998-08       Impact factor: 9.308

9.  Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: impact of bioavailability on costs and outcomes.

Authors:  Nicole Mittmann; Paul I Oh; Scott E Walker; William R Bartle
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Should university students be vaccinated against meningococcal disease in Canada?

Authors:  Philippe De Wals
Journal:  Can J Infect Dis       Date:  2004-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.